GlucoTrack ( (GCTK)) just unveiled an announcement. Glucotrack, Inc., a medical technology company, is set to present its innovative continuous blood glucose monitor at the 2024 BioFuture Conference ...
At long last, Eversense, the implantable continuous glucose monitoring system from Senseonics, has received FDA clearance to be marketed in the United States. “The FDA is committed to advancing novel ...
Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes ...
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
Rutherford, NJ & Cambridge, UK, April 02, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and ...
DETROIT, MICHIGAN - March 19, 2025 (NEWMEDIAWIRE) - Paul Goode, President & CEO, GlucoTrack (NASDAQ: GCTK), was recently a guest on Benzinga's All-Access. GlucoTrack is a medical technology company ...
Glucotrack Inc. (NASDAQ:GCTK) stock traded higher on Wednesday, with a session volume of 15.91 million compared to the average of 81.7K, according to data from Benzinga Pro. The diabetes-focused ...
Add Yahoo as a preferred source to see more of our stories on Google. A new implantable device carries a reservoir of glucagon that can be stored under the skin and could save diabetes patients from ...
US-based Sequel Med Tech has introduced its Tidepool-powered twiist automated insulin delivery (AID) system across the ...
Paul Goode, President & CEO, GlucoTrack GCTK, was recently a guest on Benzinga's All-Access. GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results